Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies.

Tong J, Meyer JH, Furukawa Y, Boileau I, Chang LJ, Wilson AA, Houle S, Kish SJ.

J Cereb Blood Flow Metab. 2013 Jun;33(6):863-71. doi: 10.1038/jcbfm.2013.19. Epub 2013 Feb 13.

2.

Positron emission tomography quantification of [11C]-harmine binding to monoamine oxidase-A in the human brain.

Ginovart N, Meyer JH, Boovariwala A, Hussey D, Rabiner EA, Houle S, Wilson AA.

J Cereb Blood Flow Metab. 2006 Mar;26(3):330-44.

PMID:
16079787
3.

Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression.

Meyer JH, Ginovart N, Boovariwala A, Sagrati S, Hussey D, Garcia A, Young T, Praschak-Rieder N, Wilson AA, Houle S.

Arch Gen Psychiatry. 2006 Nov;63(11):1209-16.

PMID:
17088501
4.

PET imaging of monoamine oxidase B in peripheral organs in humans.

Fowler JS, Logan J, Wang GJ, Volkow ND, Zhu W, Franceschi D, Pappas N, Ferrieri R, Shea C, Garza V, Xu Y, MacGregor RR, Schlyer D, Gatley SJ, Ding YS, Alexoff D.

J Nucl Med. 2002 Oct;43(10):1331-8.

5.

Greater monoamine oxidase a binding in perimenopausal age as measured with carbon 11-labeled harmine positron emission tomography.

Rekkas PV, Wilson AA, Lee VW, Yogalingam P, Sacher J, Rusjan P, Houle S, Stewart DE, Kolla NJ, Kish S, Chiuccariello L, Meyer JH.

JAMA Psychiatry. 2014 Aug;71(8):873-9. doi: 10.1001/jamapsychiatry.2014.250.

6.

Lower Monoamine Oxidase-A Total Distribution Volume in Impulsive and Violent Male Offenders with Antisocial Personality Disorder and High Psychopathic Traits: An [(11)C] Harmine Positron Emission Tomography Study.

Kolla NJ, Matthews B, Wilson AA, Houle S, Bagby RM, Links P, Simpson AI, Hussain A, Meyer JH.

Neuropsychopharmacology. 2015 Oct;40(11):2596-603. doi: 10.1038/npp.2015.106. Epub 2015 Jun 17.

7.

[11C]befloxatone distribution is well correlated to monoamine oxidase A protein levels in the human brain.

Zanotti-Fregonara P, Bottlaender M.

J Cereb Blood Flow Metab. 2014 Dec;34(12):1951-2. doi: 10.1038/jcbfm.2014.157. Epub 2014 Sep 17.

8.

Reversible inhibitors of monoamine oxidase-A (RIMAs): robust, reversible inhibition of human brain MAO-A by CX157.

Fowler JS, Logan J, Azzaro AJ, Fielding RM, Zhu W, Poshusta AK, Burch D, Brand B, Free J, Asgharnejad M, Wang GJ, Telang F, Hubbard B, Jayne M, King P, Carter P, Carter S, Xu Y, Shea C, Muench L, Alexoff D, Shumay E, Schueller M, Warner D, Apelskog-Torres K.

Neuropsychopharmacology. 2010 Feb;35(3):623-31. doi: 10.1038/npp.2009.167. Epub 2009 Nov 4.

9.

Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography.

Gulyás B, Pavlova E, Kása P, Gulya K, Bakota L, Várszegi S, Keller E, Horváth MC, Nag S, Hermecz I, Magyar K, Halldin C.

Neurochem Int. 2011 Jan;58(1):60-8. doi: 10.1016/j.neuint.2010.10.013. Epub 2010 Nov 12.

PMID:
21075154
10.

Monoamine oxidase A inhibitor occupancy during treatment of major depressive episodes with moclobemide or St. John's wort: an [11C]-harmine PET study.

Sacher J, Houle S, Parkes J, Rusjan P, Sagrati S, Wilson AA, Meyer JH.

J Psychiatry Neurosci. 2011 Nov;36(6):375-82. doi: 10.1503/jpn.100117.

11.

Kinetic modeling of the monoamine oxidase B radioligand [¹¹C]SL25.1188 in human brain with high-resolution positron emission tomography.

Rusjan PM, Wilson AA, Miler L, Fan I, Mizrahi R, Houle S, Vasdev N, Meyer JH.

J Cereb Blood Flow Metab. 2014 May;34(5):883-9. doi: 10.1038/jcbfm.2014.34. Epub 2014 Feb 12.

12.

Mapping human brain monoamine oxidase A and B with 11C-labeled suicide inactivators and PET.

Fowler JS, MacGregor RR, Wolf AP, Arnett CD, Dewey SL, Schlyer D, Christman D, Logan J, Smith M, Sachs H, et al.

Science. 1987 Jan 23;235(4787):481-5.

PMID:
3099392
13.

In vivo measurement of brain monoamine oxidase B occupancy by rasagiline, using (11)C-l-deprenyl and PET.

Freedman NM, Mishani E, Krausz Y, Weininger J, Lester H, Blaugrund E, Ehrlich D, Chisin R.

J Nucl Med. 2005 Oct;46(10):1618-24.

15.

Non-MAO A binding of clorgyline in white matter in human brain.

Fowler JS, Logan J, Ding YS, Franceschi D, Wang GJ, Volkow ND, Pappas N, Schlyer D, Gatley SJ, Alexoff D, Felder C, Biegon A, Zhu W.

J Neurochem. 2001 Dec;79(5):1039-46.

16.

Translational neuroimaging: positron emission tomography studies of monoamine oxidase.

Fowler JS, Logan J, Volkow ND, Wang GJ.

Mol Imaging Biol. 2005 Nov-Dec;7(6):377-87. Review.

PMID:
16265597
17.

11C-harmine as a tracer for monoamine oxidase A (MAO-A): in vitro and in vivo studies.

Bergström M, Westerberg G, Långström B.

Nucl Med Biol. 1997 May;24(4):287-93.

PMID:
9257326
18.

Monoamine oxidases in development.

Wang CC, Billett E, Borchert A, Kuhn H, Ufer C.

Cell Mol Life Sci. 2013 Feb;70(4):599-630. doi: 10.1007/s00018-012-1065-7. Epub 2012 Jul 11. Review.

PMID:
22782111
19.

Age-related increases in brain monoamine oxidase B in living healthy human subjects.

Fowler JS, Volkow ND, Wang GJ, Logan J, Pappas N, Shea C, MacGregor R.

Neurobiol Aging. 1997 Jul-Aug;18(4):431-5.

PMID:
9330975
20.

Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence.

Meyer JH, Wilson AA, Sagrati S, Miler L, Rusjan P, Bloomfield PM, Clark M, Sacher J, Voineskos AN, Houle S.

Arch Gen Psychiatry. 2009 Dec;66(12):1304-12. doi: 10.1001/archgenpsychiatry.2009.156.

PMID:
19996035

Supplemental Content

Support Center